Skip to main content
. Author manuscript; available in PMC: 2008 Jul 1.
Published in final edited form as: Radiother Oncol. 2007 Jun 27;84(1):75–83. doi: 10.1016/j.radonc.2007.05.025

Fig. 3.

Fig. 3

(A) MN in in situ fibroblasts used for culturing plotted against pre-op equivalent single (E.S.) dose (Gy10 for calculation based on α/β=10) (regression trend from fig 1D for the total dataset in situ is shown as a dashed line); (B) background MN in confluent cultured fibroblasts plotted against pre-op equivalent single (E.S.) dose (α/β=10); (C) background MN in confluent cultured fibroblasts plotted against corresponding values for in situ fibroblasts; (D) dose required to induce 150 MN per 1000 BN cells in confluent cultured fibroblasts vs. equivalent single (E.S.) dose (α/β=10) required to induce 400 MN per 1000 BN cells in in situ fibroblasts (in cultured fibroblasts, background was subtracted from the response values).